论文部分内容阅读
本月全球药品研发进展取得成效的药物有52个,较上月大幅减少14个。除进入注册前阶段的药品数量略有增加外,其他阶段药品数目均有一定下降。进入注册阶段的有24个,比上月增加1个。其中,6个为全球首次注册的药品,在新市场补充注册的为18个。进入注册前阶段的有7个,比上月减少11个。进入Ⅲ期临床研究阶段的有21个,比上月减少4个。
There were 52 successful medicines and drug development projects in the world this month, a sharp decrease of 14 from the previous month. Except for a slight increase in the number of drugs entering the pre-registration phase, the number of drugs in other phases decreased to a certain extent. Into the registration phase of 24, an increase over the previous month. Among them, 6 are the first drugs registered in the world and 18 are newly registered in the new market. There were seven in the pre-registration phase, a decrease of 11 from the previous month. Into the phase Ⅲ clinical research phase of 21, a decrease of 4 last month.